Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD).

Battella S, Oliva S, Franchitti L, La Scaleia R, Soriani A, Isoldi S, Capuano C, Pighi C, Morrone S, Galandrini R, Santoni A, Palmieri G.

Mucosal Immunol. 2019 Oct 3. doi: 10.1038/s41385-019-0208-7. [Epub ahead of print]

PMID:
31582819
2.

TREM1/3 Deficiency Impairs Tissue Repair After Acute Kidney Injury and Mitochondrial Metabolic Flexibility in Tubular Epithelial Cells.

Tammaro A, Scantlebery AML, Rampanelli E, Borrelli C, Claessen N, Butter LM, Soriani A, Colonna M, Leemans JC, Dessing MC, Florquin S.

Front Immunol. 2019 Jul 9;10:1469. doi: 10.3389/fimmu.2019.01469. eCollection 2019.

3.

THE TOP-IMPLART PROTON LINEAR ACCELERATOR: INTERIM CHARACTERISTICS OF THE 35 MEV BEAM.

De Angelis C, Ampollini A, Bazzano G, Della Monaca S, Ghio F, Giuliani F, Lucentini M, Montereali RM, Nenzi P, Notaro C, Placido C, Piccinini M, Ronsivalle C, Santavenere F, Soriani A, Spurio A, Strigari L, Surrenti V, Trinca E, Vadrucci M, Cisbani E, Picardi L.

Radiat Prot Dosimetry. 2019 May 29. pii: ncz142. doi: 10.1093/rpd/ncz142. [Epub ahead of print]

PMID:
31141142
4.

Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms.

Bilotta MT, Abruzzese MP, Molfetta R, Scarno G, Fionda C, Zingoni A, Soriani A, Garofalo T, Petrucci MT, Ricciardi MR, Paolini R, Santoni A, Cippitelli M.

FASEB J. 2019 Aug;33(8):9489-9504. doi: 10.1096/fj.201900319R. Epub 2019 May 24.

PMID:
31125275
5.

The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors.

Abruzzese MP, Bilotta MT, Fionda C, Zingoni A, Soriani A, Petrucci MT, Ricciardi MR, Molfetta R, Paolini R, Santoni A, Cippitelli M.

Cell Death Dis. 2019 Apr 11;10(4):324. doi: 10.1038/s41419-019-1562-9.

6.

Senescent cells: Living or dying is a matter of NK cells.

Antonangeli F, Zingoni A, Soriani A, Santoni A.

J Leukoc Biol. 2019 Jun;105(6):1275-1283. doi: 10.1002/JLB.MR0718-299R. Epub 2019 Feb 27. Review.

PMID:
30811627
7.

Dendritic cells modulate c-kit expression on the edge between activation and death.

Simonetti S, Seijas ABB, Natalini A, Vitale S, Runci D, Soriani A, Di Virgilio A, Aricò E, Gabriele L, Santoni A, Di Rosa F.

Eur J Immunol. 2019 Apr;49(4):534-545. doi: 10.1002/eji.201847683. Epub 2019 Feb 25.

PMID:
30758056
8.

Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell Response.

Vulpis E, Soriani A, Cerboni C, Santoni A, Zingoni A.

Int J Mol Sci. 2019 Jan 31;20(3). pii: E611. doi: 10.3390/ijms20030611. Review.

9.

Key Role of the CD56lowCD16low Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells.

Vulpis E, Stabile H, Soriani A, Fionda C, Petrucci MT, Mariggio' E, Ricciardi MR, Cippitelli M, Gismondi A, Santoni A, Zingoni A.

Cancers (Basel). 2018 Nov 29;10(12). pii: E473. doi: 10.3390/cancers10120473.

10.

Translating the anti-myeloma activity of Natural Killer cells into clinical application.

Fionda C, Stabile H, Molfetta R, Soriani A, Bernardini G, Zingoni A, Gismondi A, Paolini R, Cippitelli M, Santoni A.

Cancer Treat Rev. 2018 Nov;70:255-264. doi: 10.1016/j.ctrv.2018.10.005. Epub 2018 Oct 10. Review.

PMID:
30326421
11.

MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.

Zingoni A, Vulpis E, Cecere F, Amendola MG, Fuerst D, Saribekyan T, Achour A, Sandalova T, Nardone I, Peri A, Soriani A, Fionda C, Mariggiò E, Petrucci MT, Ricciardi MR, Mytilineos J, Cippitelli M, Cerboni C, Santoni A.

Front Immunol. 2018 May 1;9:926. doi: 10.3389/fimmu.2018.00926. eCollection 2018.

12.

Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation.

Borrelli C, Ricci B, Vulpis E, Fionda C, Ricciardi MR, Petrucci MT, Masuelli L, Peri A, Cippitelli M, Zingoni A, Santoni A, Soriani A.

Cancer Immunol Res. 2018 Jul;6(7):860-869. doi: 10.1158/2326-6066.CIR-17-0604. Epub 2018 Apr 24.

13.

NKG2D and Its Ligands: "One for All, All for One".

Zingoni A, Molfetta R, Fionda C, Soriani A, Paolini R, Cippitelli M, Cerboni C, Santoni A.

Front Immunol. 2018 Mar 12;9:476. doi: 10.3389/fimmu.2018.00476. eCollection 2018. Review.

14.

Chemokine regulation of innate lymphoid cell tissue distribution and function.

Soriani A, Stabile H, Gismondi A, Santoni A, Bernardini G.

Cytokine Growth Factor Rev. 2018 Aug;42:47-55. doi: 10.1016/j.cytogfr.2018.02.003. Epub 2018 Feb 14. Review.

PMID:
29472011
15.

CHARACTERIZATION OF 27 MEV PROTON BEAM GENERATED BY TOP-IMPLART LINEAR ACCELERATOR.

De Angelis C, Ampollini A, Basile E, Cisbani E, Della Monaca S, Ghio F, Montereali RM, Picardi L, Piccinini M, Placido C, Ronsivalle C, Soriani A, Strigari L, Trinca E, Vadrucci M.

Radiat Prot Dosimetry. 2018 Aug 1;180(1-4):329-333. doi: 10.1093/rpd/ncy001.

PMID:
29385620
16.

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation.

Antonangeli F, Soriani A, Cerboni C, Sciumè G, Santoni A.

Front Immunol. 2017 Nov 20;8:1583. doi: 10.3389/fimmu.2017.01583. eCollection 2017. Review.

17.

Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance.

Zingoni A, Fionda C, Borrelli C, Cippitelli M, Santoni A, Soriani A.

Front Immunol. 2017 Sep 25;8:1194. doi: 10.3389/fimmu.2017.01194. eCollection 2017. Review.

18.

Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis.

Vulpis E, Cecere F, Molfetta R, Soriani A, Fionda C, Peruzzi G, Caracciolo G, Palchetti S, Masuelli L, Simonelli L, D'Oro U, Abruzzese MP, Petrucci MT, Ricciardi MR, Paolini R, Cippitelli M, Santoni A, Zingoni A.

Oncoimmunology. 2017 Jan 13;6(3):e1279372. doi: 10.1080/2162402X.2017.1279372. eCollection 2017.

19.

GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells.

Barroeta Seijas AB, Simonetti S, Vitale S, Runci D, Quinci AC, Soriani A, Criscuoli M, Filippi I, Naldini A, Sacchetti FM, Tarantino U, Oliva F, Piccirilli E, Santoni A, Di Rosa F.

Front Immunol. 2017 Feb 16;8:147. doi: 10.3389/fimmu.2017.00147. eCollection 2017.

20.

p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells.

Soriani A, Borrelli C, Ricci B, Molfetta R, Zingoni A, Fionda C, Carnevale S, Abruzzese MP, Petrucci MT, Ricciardi MR, La Regina G, Di Cesare E, Lavia P, Silvestri R, Paolini R, Cippitelli M, Santoni A.

Oncoimmunology. 2016 Dec 2;6(1):e1264564. doi: 10.1080/2162402X.2016.1264564. eCollection 2017.

21.

Use of parallel-plate ionization chambers in reference dosimetry of NOVAC and LIAC® mobile electron linear accelerators for intraoperative radiotherapy: a multi-center survey.

Scalchi P, Ciccotelli A, Felici G, Petrucci A, Massafra R, Piazzi V, D'Avenia P, Cavagnetto F, Cattani F, Romagnoli R, Soriani A.

Med Phys. 2017 Jan;44(1):321-332. doi: 10.1002/mp.12020.

PMID:
28102948
22.

Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay.

Abruzzese MP, Bilotta MT, Fionda C, Zingoni A, Soriani A, Vulpis E, Borrelli C, Zitti B, Petrucci MT, Ricciardi MR, Molfetta R, Paolini R, Santoni A, Cippitelli M.

J Hematol Oncol. 2016 Dec 1;9(1):134.

23.

Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells.

Antonangeli F, Soriani A, Ricci B, Ponzetta A, Benigni G, Morrone S, Bernardini G, Santoni A.

Oncoimmunology. 2016 Aug 5;5(10):e1218105. eCollection 2016.

24.

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.

Nabissi M, Morelli MB, Offidani M, Amantini C, Gentili S, Soriani A, Cardinali C, Leoni P, Santoni G.

Oncotarget. 2016 Nov 22;7(47):77543-77557. doi: 10.18632/oncotarget.12721.

25.

The Carbofix™ "Piccolo Proximal femur nail": A new perspective for treating proximal femur lesion. A technique report.

Zoccali C, Soriani A, Rossi B, Salducca N, Biagini R.

J Orthop. 2016 Jul 6;13(4):343-6. doi: 10.1016/j.jor.2016.07.001. eCollection 2016 Dec.

26.

Intraoperative radiation therapy as adjuvant treatment in locally advanced stage tumours involving the middle ear: a hypothesis-generating retrospective study.

Cristalli G, Mercante G, Marucci L, Soriani A, Telera S, Spriano G.

Acta Otorhinolaryngol Ital. 2016 Apr;36(2):85-90. doi: 10.14639/0392-100X-486. Epub 2016 Apr 29.

27.

Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy.

Zingoni A, Vulpis E, Nardone I, Soriani A, Fionda C, Cippitelli M, Santoni A.

Crit Rev Immunol. 2016;36(6):445-460. doi: 10.1615/CritRevImmunol.2017020166.

PMID:
28845754
28.

Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells.

Morelli MB, Amantini C, Santoni M, Soriani A, Nabissi M, Cardinali C, Santoni A, Santoni G.

Oncotarget. 2015 Nov 3;6(34):36245-59. doi: 10.18632/oncotarget.5768.

29.

The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitro.

Dupuis ML, Fiori V, Soriani A, Ricci B, Dominici S, Moricoli D, Ascione A, Santoni A, Magnani M, Cianfriglia M.

J Immunother. 2015 Nov-Dec;38(9):357-70. doi: 10.1097/CJI.0000000000000100.

30.

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma.

Fionda C, Abruzzese MP, Zingoni A, Cecere F, Vulpis E, Peruzzi G, Soriani A, Molfetta R, Paolini R, Ricciardi MR, Petrucci MT, Santoni A, Cippitelli M.

Oncotarget. 2015 Sep 15;6(27):23609-30.

31.

NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma.

Fionda C, Soriani A, Zingoni A, Santoni A, Cippitelli M.

Biomed Res Int. 2015;2015:178698. doi: 10.1155/2015/178698. Epub 2015 Jun 16. Review.

32.

New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer.

La Regina G, Bai R, Coluccia A, Famiglini V, Pelliccia S, Passacantilli S, Mazzoccoli C, Ruggieri V, Verrico A, Miele A, Monti L, Nalli M, Alfonsi R, Di Marcotullio L, Gulino A, Ricci B, Soriani A, Santoni A, Caraglia M, Porto S, Da Pozzo E, Martini C, Brancale A, Marinelli L, Novellino E, Vultaggio S, Varasi M, Mercurio C, Bigogno C, Dondio G, Hamel E, Lavia P, Silvestri R.

J Med Chem. 2015 Aug 13;58(15):5789-807. doi: 10.1021/acs.jmedchem.5b00310. Epub 2015 Jul 20.

33.

Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

Amantini C, Morelli MB, Santoni M, Soriani A, Cardinali C, Farfariello V, Eleuteri AM, Bonfili L, Mozzicafreddo M, Nabissi M, Cascinu S, Santoni G.

Oncoscience. 2015 Mar 23;2(4):395-409. eCollection 2015.

34.

Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.

Zingoni A, Cecere F, Vulpis E, Fionda C, Molfetta R, Soriani A, Petrucci MT, Ricciardi MR, Fuerst D, Amendola MG, Mytilineos J, Cerboni C, Paolini R, Cippitelli M, Santoni A.

J Immunol. 2015 Jul 15;195(2):736-48. doi: 10.4049/jimmunol.1402643. Epub 2015 Jun 12.

35.

The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress.

Petroni M, Sardina F, Heil C, Sahún-Roncero M, Colicchia V, Veschi V, Albini S, Fruci D, Ricci B, Soriani A, Di Marcotullio L, Screpanti I, Gulino A, Giannini G.

Cell Death Differ. 2016 Feb;23(2):197-206. doi: 10.1038/cdd.2015.81. Epub 2015 Jun 12.

36.

Abscopal effect of radiation therapy: interplay between radiation dose and p53 status.

Strigari L, Mancuso M, Ubertini V, Soriani A, Giardullo P, Benassi M, D'Alessio D, Leonardi S, Soddu S, Bossi G.

Int J Radiat Biol. 2015 Mar;91(3):294. doi: 10.3109/09553002.2014.997514. Epub 2015 Feb 4. No abstract available.

PMID:
25650895
37.

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.

Fionda C, Abruzzese MP, Zingoni A, Soriani A, Ricci B, Molfetta R, Paolini R, Santoni A, Cippitelli M.

BMC Cancer. 2015 Jan 22;15:17. doi: 10.1186/s12885-015-1023-5.

38.

Monte Carlo as a tool to evaluate the effect of different lung densities on radiotherapy dose distribution.

Caccia B, Andenna C, Iaccarino G, Landoni V, Soriani A, Occhigrossi A, Esposito A, Petetti E, Valentini S, Strigari L.

Radiat Prot Dosimetry. 2014 Nov;162(1-2):115-9. doi: 10.1093/rpd/ncu241. Epub 2014 Jul 22.

PMID:
25452329
39.

Physical and dosimetric optimization of laser equipment in dermatology: a preliminary study.

Soriani A, D'Alessio D, Cattelan V, Cameli N, Mariano M, Ungania S, Guerrisi M, Strigari L.

Biomed Res Int. 2014;2014:151969. doi: 10.1155/2014/151969. Epub 2014 Sep 15.

40.

Clinical evaluation of X-ray voxel Monte Carlo versus pencil beam-based dose calculation in stereotactic body radiotherapy of lung cancer under normal and deep inspiration breath hold.

Landoni V, Borzì GR, Strolin S, Bruzzaniti V, Soriani A, D'Alessio D, Ambesi F, Di Grazia AM, Strigari L.

Technol Cancer Res Treat. 2015 Jun;14(3):334-42. doi: 10.1177/1533034614547451. Epub 2014 Sep 15.

PMID:
25223324
41.

Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1.

Soriani A, Iannitto ML, Ricci B, Fionda C, Malgarini G, Morrone S, Peruzzi G, Ricciardi MR, Petrucci MT, Cippitelli M, Santoni A.

J Immunol. 2014 Jul 15;193(2):950-60. doi: 10.4049/jimmunol.1400271. Epub 2014 Jun 9.

42.

Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma.

Soriani A, Fionda C, Ricci B, Iannitto ML, Cippitelli M, Santoni A.

Oncoimmunology. 2013 Dec 1;2(12):e26663. Epub 2013 Oct 22.

43.

The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells.

Cerboni C, Fionda C, Soriani A, Zingoni A, Doria M, Cippitelli M, Santoni A.

Front Immunol. 2014 Jan 7;4:508. doi: 10.3389/fimmu.2013.00508. eCollection 2014 Jan 7. Review.

44.

Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer.

Bruzzaniti V, Abate A, Pinnarò P, D'Andrea M, Infusino E, Landoni V, Soriani A, Giordano C, Ferraro A, Strigari L.

J Exp Clin Cancer Res. 2013 Nov 7;32:88. doi: 10.1186/1756-9966-32-88.

45.

Dose evaluation for skin and organ in hepatocellular carcinoma during angiographic procedure.

D'Alessio D, Giliberti C, Soriani A, Carpanese L, Pizzi G, Vallati G, Strigari L.

J Exp Clin Cancer Res. 2013 Oct 25;32:81. doi: 10.1186/1756-9966-32-81.

46.

Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status.

Strigari L, Mancuso M, Ubertini V, Soriani A, Giardullo P, Benassi M, D'Alessio D, Leonardi S, Soddu S, Bossi G.

Int J Radiat Biol. 2014 Mar;90(3):248-55. doi: 10.3109/09553002.2014.874608. Epub 2014 Feb 6. Erratum in: Int J Radiat Biol. 2015 Mar;91(3):294.

PMID:
24350918
47.

Inhibition of glycogen synthase kinase-3 increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3.

Fionda C, Malgarini G, Soriani A, Zingoni A, Cecere F, Iannitto ML, Ricciardi MR, Federico V, Petrucci MT, Santoni A, Cippitelli M.

J Immunol. 2013 Jun 15;190(12):6662-72. doi: 10.4049/jimmunol.1201426. Epub 2013 May 17.

48.

Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.

La Regina G, Bai R, Rensen WM, Di Cesare E, Coluccia A, Piscitelli F, Famiglini V, Reggio A, Nalli M, Pelliccia S, Da Pozzo E, Costa B, Granata I, Porta A, Maresca B, Soriani A, Iannitto ML, Santoni A, Li J, Miranda Cona M, Chen F, Ni Y, Brancale A, Dondio G, Vultaggio S, Varasi M, Mercurio C, Martini C, Hamel E, Lavia P, Novellino E, Silvestri R.

J Med Chem. 2013 Jan 10;56(1):123-49. doi: 10.1021/jm3013097. Epub 2012 Dec 27.

49.

Development and optimization of a beam shaper device for a mobile dedicated IOERT accelerator.

Soriani A, Iaccarino G, Felici G, Ciccotelli A, Pinnaro P, Giordano C, Benassi M, D'Andrea M, Bellesi L, Strigari L.

Med Phys. 2012 Oct;39(10):6080-9. doi: 10.1118/1.4749968.

PMID:
23039647
50.

Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy.

Carlino C, Trotta E, Stabile H, Morrone S, Bulla R, Soriani A, Iannitto ML, Agostinis C, Mocci C, Minozzi M, Aragona C, Perniola G, Tedesco F, Sozzani S, Santoni A, Gismondi A.

J Clin Endocrinol Metab. 2012 Oct;97(10):3603-12. doi: 10.1210/jc.2012-1102. Epub 2012 Jul 12.

Supplemental Content

Loading ...
Support Center